Clear descriptions of potential risks and side effects will be required under rules that go into effect Nov. 20, even as the ...
The full indication for vilobelimab is as a treatment for adult patients with SARS‑CoV-2‑induced ARDS who are receiving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback